SB 269
AN ACT relating to required reports of certain vaccine-related or
89th Regular Session
Jan 14, 2025 - Jun 2, 2025 • Session ended
Awaiting Committee Assignment
Bill filed, pending referral to Senate committee
Committee
Not yet assigned
Fiscal Note
Not available
What This Bill Does
relating to required reports of certain vaccine-related or
Subject Areas
Bill Text
relating to required reports of certain vaccine-related or BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Subchapter A, Chapter 161, Health and Safety Code, is amended by adding Section 161.0103 to read as follows: Sec. 161.0103. REQUIRED REPORT OF CERTAIN VACCINE-RELATED ADVERSE EVENTS. (a) In this section, "serious adverse event" means (2) is considered life-threatening; (3) results in inpatient hospitalization or an extension of the duration of an existing hospitalization; (4) results in a persistent or significant incapacity or substantial disruption of an individual's ability to perform (5) results in a congenital anomaly or birth defect; (6) results in a medically important condition that, based on the physician's reasonable medical judgment, may require medical or surgical intervention to prevent an outcome described by (b) This section applies only to a vaccine that is: (1) experimental or investigational; or (2) approved or authorized for emergency use by the United States Food and Drug Administration. (c) Notwithstanding Subsection (b), this section does not apply to a vaccine administered as part of a clinical trial. (d) Notwithstanding any other law, a physician shall report to the federal Vaccine Adverse Event Reporting System any serious adverse event the physician's patient suffers if: (A) diagnoses the patient with a condition related to the serious adverse event; and (B) knows the patient received a vaccination to which this section applies; and (2) the patient suffers the serious adverse event before the first anniversary of the date the patient was (e) A physician who violates this section is subject to: (1) for an initial violation, non-disciplinary corrective action by the Texas Medical Board; and (2) for each subsequent violation, disciplinary action by the Texas Medical Board as if the physician violated Subtitle B, Title 3, Occupations Code. (f) For purposes of non-disciplinary corrective action or disciplinary action imposed under Subsection (e), the Texas Medical Board may not consider a violation of this section after the third anniversary of the date of the violation. The Texas Medical Board shall retain information on each violation of this section in the (g) The executive commissioner shall adopt rules necessary SECTION 2. Subchapter E, Chapter 431, Health and Safety Code, is amended by adding Section 431.1145 to read as follows: Sec. 431.1145. REQUIRED REPORT OF CERTAIN DRUG-RELATED ADVERSE EVENTS. (a) In this section, "serious adverse event" means (2) is considered life-threatening; (3) results in inpatient hospitalization or an extension of the duration of an existing hospitalization; (4) results in a persistent or significant incapacity or substantial disruption of an individual's ability to perform (5) results in a congenital anomaly or birth defect; (6) results in a medically important medical condition that, based on the physician's reasonable medical judgment, may require medical or surgical intervention to prevent an outcome described by Subdivisions (1) through (5). (b) This section applies only to a drug that is: (1) experimental or investigational; or (2) approved or authorized for emergency use by the United States Food and Drug Administration. (c) Notwithstanding Subsection (b), this section does not apply to a drug that is administered or used as part of a clinical (d) Notwithstanding any other law, a physician shall report to the United States Food and Drug Administration through the MedWatch reporting program any serious adverse event the physician's patient suffers if: (A) diagnoses the patient with a condition related to the serious adverse event; and (B) knows the patient was administered or used a drug to which this section applies; and (2) the patient suffers the serious adverse event before the first anniversary of the date the patient was (e) A physician who violates this section is subject to: (1) for an initial violation, non-disciplinary corrective action by the Texas Medical Board; and (2) for each subsequent violation, disciplinary action by the Texas Medical Board as if the physician violated Subtitle B, Title 3, Occupations Code. (f) For purposes of non-disciplinary corrective action or disciplinary action imposed under Subsection (e), the Texas Medical Board may not consider a violation of this section after the third anniversary of the date of the violation. The Texas Medical Board shall retain information on each violation of this section in the (g) The executive commissioner shall adopt rules necessary SECTION 3. As soon as practicable after the effective date of this Act, the executive commissioner of the Health and Human Services Commission shall adopt rules necessary to implement the changes in law made by this Act. SECTION 4. This Act takes effect September 1, 2025.
Bill History
Bill filed: AN ACT relating to required reports of certain vaccine-related or
Related Guides
Learn more about tracking Texas legislation and working with lobbyists.
How to Read & Track Texas Bills
Master bill numbering, understand legislative language, and learn effective tracking strategies.
Understanding Texas Legislative Deadlines
Navigate the 140-day session with critical calendar dates and filing deadlines.
How Laws Get Made in Texas
Follow a bill's journey from filing to the governor's desk through committees and floor votes.
When Should Your Business Hire a Lobbyist?
Discover the signs that your business needs professional advocacy at the Texas Capitol.